Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and babies; and its Pediatrics products treat allergies, asthma, and attention deficit/hyperactivity disorder. Founded in 1992, Sciele Pharma employs more than 1,000 people. In October 2008, Shionogi & Co., Ltd. acquired Sciele, which now operates as an indirect wholly owned subsidiary of Shionogi.
Name changed to Shionogi Pharma, Inc. on January 12, 2010.
CSRHub includes data on Environment, CSR, current environmental issues, effects of climate change, Environment, Social, Governance, and global warming.